Jakarta, IO – The Food and Drug Monitoring Agency (BPOM) said two pharmaceutical companies have failed to produce syrups according to safety standards. The two companies are PT Samco Farma and PT Ciubrus Farma whose products have been found to contain excessive amount of Ethylene Glycol (EG) and Diethylene Glycol (DEG).
“There was negligence, but we need to investigate further whether it was intentional,” said BPOM chief Penny Lukito, reported CNN Indonesia, Wednesday (9/11).
“According to the guidance of Good Distribution Practice of Medicine (CDOB), upon receiving a supply from a certain distributor, a pharma wholesaler must check the quality, and that the producer or distributor has complied with the CDOB,” she said.
Read: BPOM orders the withdrawal of 69 medicinal syrups with excessive amount of EG
In addition, Penny said that every raw material or solvent received by a pharmaceutical company must be tested. So far, according to Penny, BPOM has yet to find any record showing that this has been done.
Due to this negligence, Penny said BPOM has revoked the two companies’ CDOB certificates. (un)